Paul Hastings Advised Underwriters on Humacyte's $40M Public Offering
March 02, 2024
March 02, 2024
LOS ANGELES, California, March 2 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised TD Cowen, Cantor and BTIG in connection with Humacyte, Inc's., underwritten public offering of 13,400,000 shares of common stock at $3.00 per share. The gross proceeds are expected to be approximately $40.2 million.
In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,010,000 shares of . . .
Paul Hastings LLP advised TD Cowen, Cantor and BTIG in connection with Humacyte, Inc's., underwritten public offering of 13,400,000 shares of common stock at $3.00 per share. The gross proceeds are expected to be approximately $40.2 million.
In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,010,000 shares of . . .